European Archives - Page 54 of 1531 - European Medical Journal

How Do We Define 'Appropriate Antimicrobial Use' In One Health?

Many early antimicrobial stewardship (AMS) initiatives focused on reducing antimicrobial use (AMU). However, reducing AMU may cause harm…

Investigation of Enterococcus Colonisation Impact on Clostridioides difficile Disease Severity

Enterococcus colonisation with Enterococcus faecalis and Enterococcus faecium is a known risk factor for Clostridioides difficile infection…

Addressing Prescribing Behaviour to Reduce Broad-Spectrum Antibiotic Use

Appropriate use of antibiotics is critical to combat antimicrobial resistance (AMR) and optimise patient outcomes. At the East Kent…

Microbiome Modulation as a Determinant of Cancer Therapy Response

THE ROLE of the microbiome as a modulator of cancer therapy response has become a key topic in recent oncology research. At the European…

Sex Differences in Alzheimer’s Disease

Sex Differences in Alzheimer’s Disease

In this series, host Catherine Glass speaks with Rachel Buckley about how Alzheimer’s disease risk and progression…

Cancer Risk Prediction Highlights Screening Inequalities

Individualised cancer risk models revealed marked variation in lifetime and 10-year cancer risk, with healthy behaviours associated with substantial risk reduction.

Phase 3 Trial Supports Ecopipam for Tourette Syndrome

Phase 3 Trial Supports Ecopipam for Tourette Syndrome

A phase 3 trial has found ecopipam reduces relapse risk and maintains tic improvement in children and adolescents with Tourette syndrome.

Global Study Examines Educational Impact of Atopic Dermatitis

International study finds childhood-onset atopic dermatitis may limit education, career choices, and psychosocial wellbeing into adulthood.

Stress Linked to Faster Liver Cancer Progression Through Microbiome

Stress may accelerate hepatocellular carcinoma progression by altering gut microbiota and tumour immune signalling, according to new preclinical and clinical research identifying a stress–gut–tumour axis.

VWF Biomarkers In Chronic GvHD - EMJ

Novel Biomarkers Identified for Chronic GvHD

Elevated von Willebrand factor and factor VIII levels demonstrated diagnostic potential and disease activity associations in chronic Graft-versus-Host Disease.